HCW Biologics Inc
HCWB9.421USD
-0.628-6.25%
交易中 （美東）報價延遲15分鐘
419.64M總市值
虧損本益比TTM
關於 HCW Biologics Inc 公司
HCW Biologics Inc. 是一家臨牀階段的生物製藥公司。該公司專注於發現和開發新型免疫療法，通過破壞慢性、低度炎症與年齡相關疾病（如癌症、心血管疾病、糖尿病、神經退行性疾病、自身免疫性疾病以及其他疾病，如長期 COVID-19）之間的聯繫來延長健康壽命。該公司開發了一個基於組織因子的融合 (TOBI) 發現平臺，以生成具有免疫治療特性的設計新型多功能融合分子。其主要候選產品包括 HCW9218 和 HCW9302。HCW9218 是一種雙功能免疫治療藥物，具有中和轉化生長因子-β 和刺激免疫細胞的能力，靶向衰老細胞及其分泌的 SASP 因子。HCW9302 旨在激活和擴增調節性 T 細胞，從而使炎症小體失活。其其他候選產品包括HCW9201、HCW9206等。
公司簡介
公司代碼HCWB
公司名稱HCW Biologics Inc
上市日期Jul 20, 2021
成立日期2018
CEODr. Hing C. Wong, Ph.D.
員工數量36
證券類型Ordinary Share
年結日Jul 20
公司地址2929 N Commerce Pkwy
城市MIRAMAR
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編33025
電話19548422024
網址https://hcwbiologics.com/
公司代碼HCWB
上市日期Jul 20, 2021
成立日期2018
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Dr. Hing C. Wong, Ph.D.
Dr. Hing C. Wong, Ph.D.
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
493.86K
+23.05%
Ms. Rebecca Byam
Ms. Rebecca Byam
Chief Financial Officer
Chief Financial Officer
43.01K
+24.49%
Mr. Scott T. Garrett
Mr. Scott T. Garrett
Independent Chairman of the Board
Independent Chairman of the Board
12.08K
+80.41%
Mr. Lee Flowers
Mr. Lee Flowers
Senior Vice President of Business Development
Senior Vice President of Business Development
5.72K
+20.23%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
2.73K
+543.06%
Dr. Peter Rhode, Ph.D.
Dr. Peter Rhode, Ph.D.
Chief Scientific Officer, Vice President of Clinical Operations
Chief Scientific Officer, Vice President of Clinical Operations
1.94K
+0.05%
Ms. Lisa M. Giles
Ms. Lisa M. Giles
Independent Director
Independent Director
896.00
+0.11%
Mr. Rick S. Greene
Mr. Rick S. Greene
Independent Director
Independent Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Dr. Hing C. Wong, Ph.D.
Dr. Hing C. Wong, Ph.D.
Chief Executive Officer, Founder, Director
Chief Executive Officer, Founder, Director
493.86K
+23.05%
Ms. Rebecca Byam
Ms. Rebecca Byam
Chief Financial Officer
Chief Financial Officer
43.01K
+24.49%
Mr. Scott T. Garrett
Mr. Scott T. Garrett
Independent Chairman of the Board
Independent Chairman of the Board
12.08K
+80.41%
Mr. Lee Flowers
Mr. Lee Flowers
Senior Vice President of Business Development
Senior Vice President of Business Development
5.72K
+20.23%
Mr. Gary M. Winer
Mr. Gary M. Winer
Independent Director
Independent Director
2.73K
+543.06%
Dr. Peter Rhode, Ph.D.
Dr. Peter Rhode, Ph.D.
Chief Scientific Officer, Vice President of Clinical Operations
Chief Scientific Officer, Vice President of Clinical Operations
1.94K
+0.05%
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 16 小時前
更新時間: 16 小時前
持股股東
股東類型
持股股東
股東統計
佔比
Wong (Hing C)
43.96%
Armistice Capital LLC
4.50%
Byam (Rebecca)
3.83%
Garrett (Scott T)
1.08%
Avantax Planning Partners, Inc
0.62%
Other
46.01%
持股股東
股東統計
佔比
Wong (Hing C)
43.96%
Armistice Capital LLC
4.50%
Byam (Rebecca)
3.83%
Garrett (Scott T)
1.08%
Avantax Planning Partners, Inc
0.62%
Other
46.01%
股東類型
股東統計
佔比
Individual Investor
50.05%
Hedge Fund
4.57%
Investment Advisor
1.54%
Investment Advisor/Hedge Fund
1.32%
Research Firm
0.03%
Other
42.48%
機構持股
更新時間: 3月4日 週二
更新時間: 3月4日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q1
37
530.40K
48.29%
+53.17K
2024Q4
37
23.10M
51.86%
+2.14M
2024Q3
33
21.13M
54.31%
+156.07K
2024Q2
33
21.19M
54.45%
+322.27K
2024Q1
34
20.93M
57.88%
+1.69M
2023Q4
33
19.30M
53.71%
+122.06K
2023Q3
33
19.17M
53.35%
-2.58K
2023Q2
33
22.70M
63.26%
-3.42M
2023Q1
32
22.37M
62.46%
-3.36M
2022Q4
32
22.28M
62.20%
-3.33M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Wong (Hing C)
16.05M
35.73%
--
--
Nov 22, 2024
Armistice Capital LLC
2.02M
4.5%
+2.02M
--
Dec 31, 2024
Byam (Rebecca)
1.38M
3.08%
--
--
Apr 15, 2024
Garrett (Scott T)
267.86K
0.6%
+142.86K
+114.29%
Apr 15, 2024
Avantax Planning Partners, Inc
279.54K
0.62%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
37.68K
0.08%
--
--
Dec 31, 2024
Geode Capital Management, L.L.C.
181.96K
0.4%
-1.30K
-0.71%
Dec 31, 2024
Flowers (Lee)
190.24K
0.42%
+71.43K
+60.12%
Feb 20, 2024
Cresset Asset Management, LLC
131.99K
0.29%
--
--
Dec 31, 2024
查看更多
持股ETF
更新時間: 5月6日 週二
更新時間: 5月6日 週二
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Micro-Cap ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據